Alzheimer's Disease

Alzheimer's Disease

In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. Photo: AP via UNB

FDA approves much-debated Alzheimer’s drug panned by experts

The new drug, which Biogen developed with Japan’s Eisai Co., did not reverse mental decline, only slowing it

FILE PHOTO: The headquarters of the US Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed

US approves first new Alzheimer's drug in 20 years